
PARAMOUNT - Maintenance Pemetrexed
OncoPharm
00:00
PARAMOUNT study design
John Bazar details PARAMOUNT: non‑squamous patients, cisplatin+pemetrexed induction, then pemetrexed maintenance versus placebo.
Play episode from 04:38
Transcript

John Bazar details PARAMOUNT: non‑squamous patients, cisplatin+pemetrexed induction, then pemetrexed maintenance versus placebo.